DalsnaFinance › Analyst accuracy › JPMorgan › RXO target
JPMorgan upgrades RXO stock rating on acquisition deal
JPMorgan upgraded RXO, Inc. (NYSE:RXO) from Underweight to Neutral and raised its price target to $30.00 from $22.00 following the company's acquisition announcement.
A fact about what JPMorgan published, as reported by Investing.com, not a recommendation from Dalsna Finance; JPMorgan is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.